CHAM
PNT

Clear Harbor Asset Management’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

Clear Harbor Asset Management’s Portfolio PNT Stock Details PNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,000
Closed -$66.7K – 405
2023
Q3 		$66.7K Hold
10,000
– – 0.01% 337
2023
Q2 		$90.6K Buy
+10,000
New +$88.2K 0.01% 337

Other funds holding PNT

BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Clear Harbor Asset Management's PNT Position: Q4 2023 in Review

Clear Harbor Asset Management sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 10,000 shares — an estimated $66.7K sold.

Clear Harbor Asset Management first reported a position in PNT in Q2 2023 and held it in 2 quarters. The position peaked at $90.6K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

  • Clear Harbor Asset Management reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Clear Harbor Asset Management sold 10,000 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $66.7K.
  • Clear Harbor Asset Management first reported a position in POINT Biopharma Global Inc. Common Stock in Q2 2023 and held it in 2 quarters.
  • Clear Harbor Asset Management's POINT Biopharma Global Inc. Common Stock position peaked at $90.6K in Q2 2023.
  • 1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on Clear Harbor Asset Management's 13F filing for Q4 2023, filed 18 Jan 2024.